Trials / Recruiting
RecruitingNCT05044403
Hemoperfusion in Critical Patients With Septic Multiorgan Dysfunction Syndrome.
Clinical Impact of Hemoperfusion With a Neutral Macroporous Resin Cartridge as Adjunctive Treatment in Septic Patients With Multiorgan Dysfunction Syndrome (MODS) Admitted to Intensive Care Units.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Hospital Clinic of Barcelona · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Low-level interventional clinical trial to evaluate the effectiveness and safety of extracorporeal support with hemoperfusion in critical patients with septic multiorgan dysfunction syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Extracorporeal support with haemoperfusion | Use of extracorporeal support with haemoperfusion |
| PROCEDURE | Conventional treatment | Conventional treatment |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2024-03-01
- Completion
- 2025-12-20
- First posted
- 2021-09-14
- Last updated
- 2025-06-10
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05044403. Inclusion in this directory is not an endorsement.